Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jane A. Gross0
Mark W. Rixon0
Date of Patent
March 10, 2009
0Patent Application Number
112422940
Date Filed
October 3, 2005
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
